Adverse Drug Reactions Associated with Cancer Immunotherapy: Mechanisms, Clinical Spectrum, and Management Strategies
Indian Journal of Pharmacy Practice · 28.07.2026 · 19 (4) · 447-450
DOI: 10.5530/ijopp.20260743 ↗Kurz gefasst
Fachartikel in der Zeitschrift Indian Journal of Pharmacy Practice, online erschienen am 28.07.2026. Verfasst von Darshan TM und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Cancer immunotherapy has substantially reshaped contemporary oncology by improving survival outcomes across solid tumours and haematological malignancies. Immune Checkpoint Inhibitors (ICIs) and Chimeric Antigen Receptor T-cell (CAR-T) therapies enhance antitumor immune activity but are associated with a distinctive spectrum of immune-mediated adverse drug reactions, collectively termed immune-Related Adverse Events (irAEs). These toxicities may involve virtually any organ system and range from mild, self-limiting manifestations to severe, life-threatening complications requiring aggressive immunosuppression. This review provides a structured synthesis of the mechanisms, clinical manifestations, grading systems, and evidence-based management strategies for immunotherapy-associated adverse reactions, with particular emphasis on ICIs and CAR-T therapies. Updated international consensus recommendations are incorporated to support standardized clinical practice. Structured pharmacovigilance frameworks and multidisciplinary collaboration-including formal integration of clinical pharmacists-are emphasized as critical components to improve early detection, optimize toxicity management, and enhance patient safety outcomes.
Zitieren
APA
TM, D., Ramaiah, B., & Kumar, D. (2026). Adverse Drug Reactions Associated with Cancer Immunotherapy: Mechanisms, Clinical Spectrum, and Management Strategies. Indian Journal of Pharmacy Practice, 19(4), 447-450. https://doi.org/10.5530/ijopp.20260743
Vancouver
TM D, Ramaiah B, Kumar D. Adverse Drug Reactions Associated with Cancer Immunotherapy: Mechanisms, Clinical Spectrum, and Management Strategies. Indian Journal of Pharmacy Practice. 2026;19(4):447-450. doi:10.5530/ijopp.20260743
BibTeX
@article{TM2026,
author = {TM, Darshan and Ramaiah, Balakeshwa and Kumar, Delvin},
title = {Adverse Drug Reactions Associated with Cancer Immunotherapy: Mechanisms, Clinical Spectrum, and Management Strategies},
journal = {Indian Journal of Pharmacy Practice},
year = {2026},
volume = {19},
number = {4},
pages = {447--450},
doi = {10.5530/ijopp.20260743}
}
EUVIMED